ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025
Stress-related genetic factors modify the effect of socioeconomic status on cardiovascular risk.
Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Immuno-inflammatory-metabolic interactions in cardiovascular diseases: a review from basic mechanisms to clinical translation.Frontiers in immunology · 2026Review
- Imaging Findings Associated With Socioenvironmental Exposures Inform Mechanisms of Cardiovascular Disease.Arteriosclerosis, thrombosis, and vascular biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Lower socioeconomic status (SES) and higher neuroticism polygenic risk score (NEU-PGS) associate with cardiovascular disease (CVD). Chronic stress increases CVD risk via activation of neural, autonomic, and immune pathways. We evaluated whether 1) higher NEU-PGS accentuates the association between lower SES and major adverse cardiovascular events (MACE); and 2) higher stress-associated neural activity and C-reactive protein and lower heart rate variability contribute to the SES-MACE link among those with higher NEU-PGS. NEU-PGS (from those with European ancestry) and SES data were derived from individuals in the Mass General Brigham Biobank. SES was assessed as median household income (N = 18,093) and area deprivation index (ADI, N = 15,276). Lower household income was defined as the lowest tertile and higher ADI as the highest. NEU-PGS was stratified about the population median. MACE, stress-associated neural activity, heart rate variability, and C-reactive protein were assessed from clinical data. Among individuals with higher (but not lower) NEU-PGS, lower household income associated with MACE (N = 6,574; OR: 1.22, p = 0.005), stress-associated neural activity (N = 480; standardized β: 0.14, p = 0.003), and heart rate variability (1,361; -0.05, p = 0.041). Higher ADI associated with MACE (5,441; 1.24, p = 0.008) and heart rate variability (1,127; -0.09, p = 0.001) among those with higher (but not lower) NEU-PGS. Lower SES associated with higher C-reactive protein across NEU-PGS groups. The mediating effect of stress-associated neural activity, heart rate variability and C-reactive protein in the SES-MACE relationship was moderated by higher NEU-PGS. Individuals with higher NEU-PGS experience greater CVD risk related to lower SES via alterations in neural, autonomic, and immune mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.